PharmiWeb Today Story
GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire(opens new window)/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve performance and durable clinical outcomes. The findings were presented as late-breaking clinical science at the American College of Cardiology's Annual Scientific Session & Expo and simultaneously published in the JACC, the flagship journal of the American College of Cardiology(opens new window).
The Evolut Low Risk Trial was a randomized, multicenter, international study assessing the safety and efficacy of the Evolut TAVR system versus surgery in low-risk patients. These patients had a predicted 30-day mortality risk <3%, as assessed by a local heart team. 1,414 patients were randomized, with 730 receiving TAVR with either a Medtronic Evolut R, PRO, or CoreValve™ and 684 undergoing surgery.
"Results at five years support Evolut's supra-annular, self-expanding TAVR as a safe, effective, and durable alternative to surgery for patients with severe aortic stenosis, regardless of their surgical risk," said Michael J. Reardon, M.D., Allison Family Distinguished Chair of Cardiovascular Research and professor of cardiothoracic surgery at the Houston Methodist Hospital and principal investigator of the trial. "The…
Read More...
Articles

What Does a Pharmaceutical Account Manager Do?
04-Mar-2025

Top 10 Highest Paying Pharma Jobs in 2025
18-Feb-2025

The Impact of AI on Pharmaceutical Sales
13-Feb-2025

What Does a Medical Science Liaison Do?
18-Sep-2023
Featured Events

-
Reuters Events: Pharma 2021
11-Oct-2021 - 22-Oct-2021 -
UK Clinical Research: A Professional Awareness Upd…
26-Jan-2022 - 27-Jan-2022 -
PM Society: Measuring Patient Engagement: Opening…
12-Oct-2022 - 12-Oct-2022 -
AI in Healthcare Summit Boston 2022
13-Oct-2022 - 14-Oct-2022 -
How to impact, influence & inspire
07-Feb-2023 - 21-Feb-2023 -
Reuters Events: Pharma USA 2023
28-Mar-2023 - 29-Mar-2023
News

-
MedMira Reports Second Quarter Results FY2025
01-Apr-2025 -
Viromed Medical AG: UMECO Group acquires exclusive…
01-Apr-2025 -
Sunshine Biopharma Reports Revenue of $34.9M in Fi…
01-Apr-2025 -
Total Health Revive on Why Modern Medicine is Fail…
01-Apr-2025 -
Jaguar Health Announces Closing of Bridge Financin…
01-Apr-2025 -
Viromed Medical AG: UMECO Group Acquires Exclusive…
01-Apr-2025